First Horizon Advisors’s AngioDynamics ANGO Stock Holding History

First Horizon Advisors’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1,264	Closed	-$12K	–	1427
2020 Q2	$12K	Hold	1,264	–	–	﹤0.01%	951
2020 Q1	$13K	Hold	1,264	–	–	﹤0.01%	867
2019 Q4	$20K	Hold	1,264	–	–	﹤0.01%	854
2019 Q3	$23K	Hold	1,264	–	–	﹤0.01%	793
2019 Q2	$24K	Hold	1,264	–	–	﹤0.01%	810
2019 Q1	$28K	Buy	1,264 +375	+42%	+$8.14K	﹤0.01%	692
2018 Q4	$17K	Hold	889	–	–	﹤0.01%	851
2018 Q3	$19K	Buy	+889	New	+$19.7K	﹤0.01%	891

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

First Horizon Advisors's ANGO Position: Q3 2020 in Review

First Horizon Advisors sold out of AngioDynamics (ANGO) in Q3 2020, closing a stake of 1,264 shares — an estimated $12K sold.

First Horizon Advisors first reported a position in ANGO in Q3 2018 and held it in 8 quarters. The position peaked at $28K in Q1 2019. 138 funds tracked by Wall St. Rank hold ANGO as of Q3 2020.

First Horizon Advisors reported no remaining AngioDynamics position as of Q3 2020 after selling out during the quarter.
First Horizon Advisors sold 1,264 AngioDynamics shares in Q3 2020, an estimated $12K.
First Horizon Advisors first reported a position in AngioDynamics in Q3 2018 and held it in 8 quarters.
First Horizon Advisors's AngioDynamics position peaked at $28K in Q1 2019.
138 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2020.

Based on First Horizon Advisors's 13F filing for Q3 2020, filed 12 Nov 2020.